She had to fight for recognition after a male colleague took credit for her work in identifying an extra chromosome as the ...

The 29-year-old suspect shot himself in the head after the crash and remains hospitalized in critical condition.

Optus network customers have reported more emergency triple-0 call failures outside the hours of recently confirmed outage periods in September. Those outages resulted in hundreds of emergency calls ...

The latest meltdown prompted anger from both sides of politics, with Jim Chalmers branding it a “shocking failure”, opposition communications spokeswoman Melissa McIntosh saying it put “lives at risk” ...

In a new study published in Nature Communications, researchers from the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz discovered important ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...

The global Triple X Syndrome Management Market is poised for significant growth over the next decade, with projections indicating an increase from USD 168.5 million in 2025 to USD 301.8 million by ...

Servier is souping up its neurology pipeline with a clinical-stage candidate sourced from U.K. biotech Kaerus Bioscience for a rare genetic disease. The French pharma is offering as much as $450 ...

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan ...

Les Laboratoires Servier said that it agreed to acquire a potential treatment for Fragile X syndrome (FXS), the most common genetic cause of autism spectrum disorder (ASD), from its original developer ...

Researchers at The Hospital for Sick Children (SickKids) have uncovered a promising new therapeutic target for Barth syndrome, a rare genetic condition with no current cure. Barth syndrome is an ...